BioStrand: Funding, Investors & Team (Sep 2026)
BioStrand offers a revolutionary methodology for identifying similarities and variations in genetic data and detecting structural anchor points that will drive innovation in precision medicine, drug development and agriculture. The BioStrand methodology enables unprecedented accuracy in detecting similarities and variations in DNA, RNA and proteins. By detecting HYFTSTM, structural 3D information is automatically integrated into the analyses, revolutionising pattern and profile detection that are critical in unraveling diseases and biological processes.
BioStrand has raised $490k across 1 funding round on record, the most recent a Grant of $490k announced in May 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioStrand Company Profile and Key Stats
Latest funding round on record: May 2022.
BioStrand Funding Rounds
BioStrand Founders and Leadership Team
Contact details for the BioStrand team: 1 of 1 has an email address on file.
Start 14-day free trial →BioStrand Funding Compared to Other Biotechnology Startups
BioStrand's latest round of $490k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioStrand in Biotechnology and Diepenbeek
Companies Similar to BioStrand
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
Nyxoah is a health-technology company focused on the development and commercialization of innovative…
Coultreon Biopharma is developing best-in-class therapeutics that target clinically validated pathways in…
neuroClues provides easy-to-use eye-tracking environment to help practitioners instantaneously quantify their…
Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells,…
Confo Therapeutics is a company focused on drug discovery, specifically targeting GPCRs to address medical…
Animab is a biotech company that focuses on developing unique technology to enhance the health of livestock.…
Augustine Therapeutics company is conducting two drug discovery programs in order to discover new generations…
4Tissue is a company focused on research and clinical trials that creates remedies to address the challenges…
Tavira Therapeutics creates an innovative platform to improve the delivery of genes using AAV. By adding…
AgomAb is creating sub-atomic treatments for the recovery of harmed tissues. Their exceptional agonistic…
BioStrand Funding FAQs
What does BioStrand do?
BioStrand offers a revolutionary methodology for identifying similarities and variations in genetic data and detecting structural anchor points that will drive innovation in precision medicine, drug development and agriculture. The BioStrand methodology enables unprecedented accuracy in detecting similarities and variations in DNA, RNA and proteins. By detecting HYFTSTM, structural 3D information is automatically integrated into the analyses, revolutionising pattern and profile detection that are critical in unraveling diseases and biological processes.
How much funding has BioStrand raised?
BioStrand has raised $490k across 1 round on record. The most recent is a Grant of $490k announced in May 2022.
When did BioStrand last raise funding?
BioStrand's most recent funding round on record is a Grant of $490k, announced in May 2022.
Who is the CEO of BioStrand?
Ingrid Brands is listed as CEO at BioStrand.
Where is BioStrand headquartered?
BioStrand is based in Diepenbeek, Limburg, Belgium.
How many employees does BioStrand have?
BioStrand is in the 11-50 employee band.
How does BioStrand's funding compare to other Biotechnology startups?
BioStrand's latest round of $490k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's BioStrand Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioStrand is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.